Through Johnson & Johnson partner Pathfinder International, young people learn good health and life skills.

Johnson & Johnson is a company of 128,000 individuals in 60 countries with one single purpose: To help people everywhere live longer, healthier, happier lives.  Our work to defeat HIV/AIDS is one important way we do that.

An estimated 34 million people are living with HIV, and 2.6 million people become infected every year. In response to the epidemic, Johnson & Johnson partners with more than 100 community-based organizations in more than 40 countries.

Here is where you can find out more about the partners we work with, the programs we support, the medicines in our pipeline and the people and patients around the world who are an inspiration.


On JNJ.com:

• Here you can explore a map to learn more about the stories and programs of our partners in combating HIV/AIDS.
• We have a global access program for our HIV/AIDS medicines and have active research programs for diseases that affect the developing world.
• View our pipeline of Selected Pharmaceuticals in Late-Stage U.S. and E.U. Development or Registration (opens as PDF).

On our company blog, JNJ BTW:

• From Paul Stoffels, Worldwide Chairman, Pharmaceuticals Group, Johnson & Johnson , Fighting HIV/AIDS, Part of Our Commitment to Caring.

On janssenrnd.com:

• As the pharmaceutical research and development organization within Johnson & Johnson, Janssen R&D is directly engaged in research and development of a broad range of products that impact human health and well-being. Here you can read about Janssen’s Global Access and Partnership program, and download its 2012 Program Overview PDF.

On the JNJ Health Channel on YouTube:

• A collection of videos highlight the people with HIV that inspire us, and the programs we support.